Article
Personalizing therapy in advanced non-small cell lung cancer.
Seminars in respiratory and critical care medicine - 1 Dec 2013
Villaruz Liza C, Burns Timothy F, Ramfidis Vasilis S, Socinski Mark A
Abstract excerpt
The recognition that non-small cell lung cancer (NSCLC) is not a single disease entity, but rather a collection of distinct molecularly driven neoplasms, has permanently shifted the therapeutic landscape of NSCLC to a personalized approach. This personalization of NSCLC therapy is typified by the dramatic response rates seen in EGFR mutant NSCLC when treated with targeted tyrosine kinase inhibitor therapy and in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.